PLN 119.0
(2.59%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 8617.89 PLN | 2534773.53% |
2022 | -0.34 PLN | -134.0% |
2021 | 1.00 PLN | -99.99% |
2020 | 11.84 Thousand PLN | 116.17% |
2019 | 5477.61 PLN | 448884.43% |
2018 | 1.22 PLN | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 31.24 Thousand PLN | 262.54% |
2024 Q2 | 21.12 Thousand PLN | -32.4% |
2023 FY | 8617.89 PLN | 2534773.53% |
2023 Q1 | 2.00 PLN | 688.24% |
2023 Q4 | 8617.89 PLN | 861689.0% |
2023 Q3 | 1.00 PLN | 0.0% |
2023 Q2 | 1.00 PLN | -50.0% |
2022 Q4 | -0.34 PLN | -100.0% |
2022 Q2 | 13.81 Thousand PLN | 66.14% |
2022 Q1 | 8317.71 PLN | 831671.0% |
2022 Q3 | 11.41 Thousand PLN | -17.37% |
2021 Q3 | 94.5 Thousand PLN | 0.0% |
2021 Q4 | 1.00 PLN | -100.0% |
Name | Inventory | Inventory Difference |
---|---|---|
BIOTON S.A. | 117.91 Million PLN | 99.993% |
Captor Therapeutics Spolka Akcyjna | - PLN | -Infinity% |
Mabion S.A. | 6.84 Million PLN | 99.874% |
Molecure S.A. | - PLN | -Infinity% |
NanoGroup S.A. | 63.37 Thousand PLN | 86.402% |
Pharmena S.A. | 445 Thousand PLN | 98.063% |
Poltreg S.A. | 415 Thousand PLN | 97.923% |
Pure Biologics Spólka Akcyjna | 17.56 Million PLN | 99.951% |
Ryvu Therapeutics S.A. | 2.11 Million PLN | 99.593% |
Synthaverse S.A. | 15.48 Million PLN | 99.944% |
Urteste S.A. | 162 Thousand PLN | 94.68% |